InvestorsHub Logo
Followers 36
Posts 4013
Boards Moderated 0
Alias Born 03/26/2013

Re: None

Friday, 03/24/2017 12:48:05 AM

Friday, March 24, 2017 12:48:05 AM

Post# of 203913
There is no scam going on here. All you need to do is realize that Kodiak via their proxies plus other competitors via their proxies are trying successfully hard to keep this down. This ticket should be trading at least at $3.57 pre revenue.
I'm convinced that the company should have placed a percentage (%) on the efficacy test. By not doing so, it gave the impression (which becomes reality) that they are not done testing. Another reason for not disclosing is not to tip competitors until they are ready to release full disclosure including full blown patent.
I read the claims off some posters indicating the company only put $30K in research while other companies spend millions. Well, if the company is being manage properly, as they have shown by the deals the made for financing, you want them to spend what is necessary, not over spend. This is actually a great sign as they know what they are looking for and not throwing darts.
I'm vey happy with my INVESTMENT (not trade, not flip). If any of you doubts if you should jump in or not because this ticker left penny land, don't doubt. I am sure that you or me would have purchase at $15 per share if we knew it would be today. A properly manage company is worth a lot more that a big company that missuses shareholders capital. Be happy management is conservative with their spending to accomplish GREAT and SIGNIFICANT goals.
GLTA